Etripamil
MSP-2017-1109
Phase 2 small_molecule completed
Quick answer
Etripamil for Paroxysmal Supraventricular Tachycardia (PSVT) is a Phase 2 program (small_molecule) at Milestone Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Milestone Pharmaceuticals
- Indication
- Paroxysmal Supraventricular Tachycardia (PSVT)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed